000 01381nam##2200265za#4500
0019.559966
003CaOODSP
00520210624173132
007cr |||||||||||
008150406|2005||||xxc|||||o    f|0| 0 eng|d
020 |a0-662-42136-1
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH81-1/1-2005E-PDF
1101 |aCanada. |bPatented Medicine Prices Review Board.
24514|aThe impact upon public drug plans of changes in drug distribution |h[electronic resource]
260 |bPatented Medicine Prices Review Board |cNovember 2005.
300 |a24p.|bfig., graphs, references, tables
4901 |aNational Prescription Drug Utilization Information System - analytical study series
500 |aThe catalogue number (H81-1/1-2005) and ISBN (0-662-69492-9) for the bilingual print edition have been incorrectly copied in this electronic publication.
590 |a12-01-Supp|b2012-01-13
69007|aPrescription drugs|2gcpds
77508|tIncidence des nouvelles formules de distribution des médicaments d'ordonnance sur les budgets des régimes publics d'assurance-médicaments |w(CaOODSP)9.592677
830#0|aNational Prescription Drug Utilization Information System - analytical study series.|w(CaOODSP)9.504983
85640|ahttp://publications.gc.ca|qPDF|s438 KB|uhttps://publications.gc.ca/collections/collection_2011/cepmb-pmprb/H81-1-1-2005-eng.pdf